[ad_1] By Martin Spieler, July 12, 2018 Risky Investment: Evolva is hoping for the resounding success of the Stevia Artificial Sweetener. Photo: Getty Images At the beginning of the year, I bought …
Read More »Moving with Evolva – but only in management
[ad_1] Comment The small biotech company has taken the patience of investors hard in recent years. That will not change anything, a glimmer of hope brings the newly appointed CEO. Werner Grundlehner …
Read More »